Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma

British Journal of Cancer

Volumn 86, Issue 3, 2002, Pages 417-423

  Werther, K ^a   Christensen, I J ^a   Nielsen, H J ^a   Schulze, S ^a   Thorup, J ^a   Wille Jorgensen P ^a   Bentzen, E ^a   Christoffersen, I ^a   Moller P ^a   Banke, L ^a   Froberg, D ^a   Henriksen, F W ^a   Crone, P ^a   Hesselfeldt, P ^a   Hempel Sparso B ^a   Lindorff Larsen, K ^a   Asmussen, T ^a   Heiner, J ^a   Hart Hansen, O ^a   Flyger, H ^a   Jess, P ^a   Iversen, J ^a   La Cour Andersen, J ^a   Vennits, B ^a   Moesgaard, F ^a   Hammer, J ^a   Fischer, A ^a   Galatius, H ^a   Naver, L ^a   Teilum, D ^a   Holbraad, L ^a   Iversen, O ^a   Nymark, J ^a   Roikjaer O ^a   Svendsen, L B ^a   Vedel, L ^a   Palm, L ^a   Rasmussen, K C ^a   Friis, J ^a   Lanng, C ^a   Wiboltt, K ^a   Jensen, N C ^a   Hoffman, N ^a   Larsen, T ^a   Packler, J ^a   more..

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Angiogenesis; Colorectal cancer; Prognosis; VEGF

Indexed keywords

VASCULOTROPIN;

ARTICLE; BLOOD LEVEL; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM STAGING; RECTAL NEOPLASMS; REFERENCE VALUES; SURVIVAL RATE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 18244387773     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600075     Document Type: Article

References (12)

1. Release of the cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology
2. The hemostatic system as a regulator of angiogenesis
3. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer
4. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: Clinical evidence of platelet scavenging?
5. Inhibition of metastases by anticoagulants
6. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: Which is the optimal specimen?
7. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer
8. Soluble vascular endothelial growth factor in various blood transfusion components
9. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor
10. Serum VEGF levels in women with a benign breast tumor or breast cancer
11. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical disease
12. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma